Drug Free Solution Inc
Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. Its Living Breath Process is a three-step process that combines self-analysis, breath, and language addressing various markets, including addiction/prevention, self help, emotional wellness, and lifestyle. The company also offers the Living Breath Series of programs w… Read more
Drug Free Solution Inc (DSOL) - Net Assets
Latest net assets as of February 2014: $-339.23 USD
Based on the latest financial reports, Drug Free Solution Inc (DSOL) has net assets worth $-339.23 USD as of February 2014.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($52.26) and total liabilities ($391.49). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-339.23 |
| % of Total Assets | -649.12% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 567.7 |
Drug Free Solution Inc - Net Assets Trend (2011–2020)
This chart illustrates how Drug Free Solution Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Drug Free Solution Inc (2011–2020)
The table below shows the annual net assets of Drug Free Solution Inc from 2011 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-05-31 | $-280.79K | -17.86% |
| 2019-05-31 | $-238.25K | -369.09% |
| 2013-05-31 | $-50.79K | -353.63% |
| 2012-05-31 | $20.02K | +781.77% |
| 2011-05-31 | $2.27K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Drug Free Solution Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 519002300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (May 2020)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $427.63K | % |
| Other Comprehensive Income | $4.91 Million | % |
| Total Equity | $-280.79K | 100.00% |
Drug Free Solution Inc Competitors by Market Cap
The table below lists competitors of Drug Free Solution Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Oasis Hotel Resort & Casino I
PINK:OHTR
|
$1.87 |
|
FNDS3000 Corp
PINK:FDTC
|
$1.87 |
|
MHHC Enterprises Inc
OTCQB:MHHC
|
$1.87 |
|
Crown Cap Ventures Ltd
PINK:CCVL
|
$1.87 |
|
Lake Victoria Mining
PINK:LVCA
|
$1.87 |
|
Benchmark Energy Corporation
PINK:GPLL
|
$1.86 |
|
Pervasip Corp
PINK:PVSP
|
$1.86 |
|
Microart Inc
OTCGREY:MCRT
|
$1.86 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Drug Free Solution Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from -238,252 to -280,792, a change of -42,540.
- Net loss of 1,407,275 reduced equity.
- Other comprehensive income increased equity by 1,364,734.
- Other factors increased equity by 1.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.41 Million | -501.18% |
| Other Comprehensive Income | $1.36 Million | +486.03% |
| Other Changes | $1.00 | +0.0% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Drug Free Solution Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-05-31 | $0.00 | $0.00 | x |
| 2013-05-31 | $-0.60 | $0.00 | x |
| 2019-05-31 | $0.00 | $0.00 | x |
| 2020-05-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Drug Free Solution Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -174816.77%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-624.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | 0.00% | 0.00x | 1.26x | $-227.10 |
| 2012 | -3124.02% | 0.00% | 0.00x | 1.00x | $-627.59K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-750.79K |
| 2019 | 0.00% | -82242.81% | 0.10x | 0.00x | $-1.43 Million |
| 2020 | 0.00% | -174816.77% | 0.02x | 0.00x | $-1.38 Million |
Industry Comparison
This section compares Drug Free Solution Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Drug Free Solution Inc (DSOL) | $-339.23 | 0.00% | N/A | $1.87 |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |